ArticleClinical and translational medicine2023

Identification of 3'-terminal 2'-O-methylated miRNA in plasma as a novel diagnostic biomarker of NSCLC.

Xu Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.